Physician profile
Catherine Gu
NPI 1073298634
$1,567.20
in general payments reported to CMS, 2019-2025
13 companies · $786 in 2025
The $786 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $157 · 2024: $625 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $566.52 | 2023-2025 | Vemlidy |
| Boston Scientific Corporation | $247.04 | 2024 | Ams 700 Cxr Rte Kit |
| Ani Pharmaceuticals, INC. | $164.16 | 2024-2025 | Purified Cortrophin Gel |
| Exact Sciences Corporation | $138.44 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $86.81 | 2024-2025 | Mounjaro, Kisunla, Zepbound |
| Astrazeneca Pharmaceuticals LP | $79.56 | 2024-2025 | Farxiga, Airsupra |
| Kowa Pharmaceuticals America, INC. | $78.58 | 2025 | Zoryve |
| Novo Nordisk INC | $60.28 | 2024 | Ozempic, Rybelsus |
| Amgen INC. | $55.48 | 2024-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $37.89 | 2025 | |
| Merck Sharp & Dohme LLC | $24.11 | 2025 | Capvaxive, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $15.11 | 2024 | Xarelto |
| Pfizer INC. | $13.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.